Supporting information_Role of transient receptor potential vanilloid 4 in therapeutic anti-fibrotic effects of pirfenidone by Koji Kuronuma (9638138)

“…Finally, we showed that changes in forced vital capacity of patients with IPF treated with pirfenidone were significantly correlated with metabolite levels of TRPV4 endogenous ligands in bronchoalveolar lavage fluid. …”

Role of transient receptor potential vanilloid 4 in therapeutic anti-fibrotic effects of pirfenidone by Koji Kuronuma (9638138)

“…Finally, we showed that changes in forced vital capacity of patients with IPF treated with pirfenidone were significantly correlated with metabolite levels of TRPV4 endogenous ligands in bronchoalveolar lavage fluid. …”

Fig 5 - by Kun Huang (136241)

Subjects:

The minimal data. by Kun Huang (136241)

Subjects:

Fig 3 - by Kun Huang (136241)

Subjects:

Baseline characteristics of patients with PSRCC. by Kun Huang (136241)

Subjects:

Fig 2 - by Kun Huang (136241)

Subjects:

Univariate Cox regression analysis of CSS and OS in PSRCC patients. by Kun Huang (136241)

Subjects:

Fig 4 - by Kun Huang (136241)

Subjects:

Fig 1 - by Kun Huang (136241)

Subjects:

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

Contact structure can have a significant impact on the population immunity threshold. by Simon Bauer (11378195)

In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway. by Leemon Nikhila (22250736)

Presentation_1_A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resi... by Li Liu (75607)

“…</p>Conclusion<p>Our study provides real-world clinical evidence from a large cohort that simultaneous inhibition of EGFR and MET could be a more effective therapeutic strategy for patients with MET-amp acquired from EGFR-TKI therapy.…”

DataSheet_1_Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study.pdf by Willem Daneels (12157263)

“…<p>We determined first- and second-line regimens, including hematopoietic stem cell transplantations, in all diffuse large B cell lymphoma (DLBCL) patients aged ≥20 yr (n = 1,888), registered at the Belgian Cancer Registry (2013–2015). …”

DataSheet_1_Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study.pdf by Willem Daneels (12157263)

“…<p>We determined first- and second-line regimens, including hematopoietic stem cell transplantations, in all diffuse large B cell lymphoma (DLBCL) patients aged ≥20 yr (n = 1,888), registered at the Belgian Cancer Registry (2013–2015). …”

Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis... by Kristian Reich (3344690)

“…This study examines effectiveness of FAEs for the treatment of plaque psoriasis in real-world practice at 12 months and if patient characteristics affect the odds of clinical response.…”

Expression of tight junction proteins. by Maj Schneider Thomsen (10297019)

Expression and functionality of efflux transporters. by Maj Schneider Thomsen (10297019)

Interaction strength in plant-pollinator networks: Are we using the right measure? by Roberto Novella-Fernandez (8119745)

“…Interaction evenness also decreased strongly with the visit-based approach. We conclude that accounting for the number of flowers visited per encounter provides a more ecologically relevant measure of interaction strength. …”